|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2011-10-12
|
|
pubmed:abstractText |
Idiopathic pulmonary fibrosis (IPF) is a devastating disease. Antiinflammatory therapies, including corticosteroids, are of no benefit. The role of monocytes and macrophages is therefore controversial.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1535-4970
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
184
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
569-81
|
|
pubmed:meshHeading |
pubmed-meshheading:21680953-Animals,
pubmed-meshheading:21680953-Bleomycin,
pubmed-meshheading:21680953-Disease Models, Animal,
pubmed-meshheading:21680953-Disease Progression,
pubmed-meshheading:21680953-Female,
pubmed-meshheading:21680953-Humans,
pubmed-meshheading:21680953-Immunity, Cellular,
pubmed-meshheading:21680953-Macrophage Activation,
pubmed-meshheading:21680953-Macrophages, Alveolar,
pubmed-meshheading:21680953-Mice,
pubmed-meshheading:21680953-Monocytes,
pubmed-meshheading:21680953-Phenotype,
pubmed-meshheading:21680953-Pulmonary Fibrosis
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis.
|
|
pubmed:affiliation |
Medical Research Council/University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, United Kingdom.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
